Novanta Inc 2026年季度报告

☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIESEXCHANGE ACT OF 1934 For the quarterly period ended April 3, 2026Or TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIESEXCHANGE ACT OF 1934For the transition period from __________ to __________Commission File No.: 001-35083 NOVANTA INC. (Exact name of registrant as specified in its charter) New Brunswick, Canada98-0110412(State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification No.) Securities registered pursuant to Section 12(b) of the Act: Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of theSecurities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to filesuch reports), and (2) has been subject to such filing requirements for the past 90 days.YES☒NO☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to besubmitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorterperiod that the registrant was required to submit such files).YES☒NO☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, asmaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,”“smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition periodfor complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).YES☐NO☒ As of May 4, 2026, there were 35,611,858 of the Registrant’s common shares, no par value, issued and outstanding. NOVANTA INC. TABLE OF CONTENTS Item No.PageNo.PART I — FINANCIAL INFORMATION1ITEM 1.FINANCIAL STATEMENTS1CONSOLIDATED BALANCE SHEETS (unaudited)1CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited)2CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (unaudited)3CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (unaudited)4CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)5NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)6ITEM 2.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION ANDRESULTS OF OPERATIONS29ITEM 3.QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK38ITEM 4.CONTROLS AND PROCEDURES38PART II — OTHER INFORMATION39ITEM 1.LEGAL PROCEEDINGS39ITEM 1A.RISK FACTORS39ITEM 2.UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS40ITEM 3.DEFAULTS UPON SENIOR SECURITIES40ITEM 4.MINE SAFETY DISCLOSURES40ITEM 5.OTHER INFORMATION40ITEM 6.EXHIBITS41SIGNATURES42 NOVANTA INC.CONSOLIDATED BALANCE SHEETS(In thousands of U.S. dollars or shares)(Unaudited) NOVANTA INC.CONSOLIDATED STATEMENTS OF OPERATIONS(In thousands of U.S. dollars or shares, except per share amounts)(Unaudited) NOVANTA INC.CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)(In thousands of U.S. dollars)(Unaudited) The tax effect on this component of comprehensive income (loss) was nominal for all periods presented.The tax effect on this component of comprehensive income (loss) was nominal for all periods presented. See Note 4 to theConsolidated Financial Statements for the total amount of pension liability adjustments reclassified out of accumulated othercomprehensive income (loss).(1)(2) The accompanying notes are an integral part of these consolidated financial statements. NOVANTA INC.CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY(In thousands of U.S. dollars or shares)(Unaudited) The accompanying notes are an integral part of these consolidated financial statements. NOVANTA INC.CONSOLIDATED STATEMENTS OF CASH FLOWS(In thousands of U.S. dollars)(Unaudited) NOVANTA INC.NOTES TO CONSOLIDATED FINANCIAL STATEMENTSAS OF APRIL 3, 2026(Unaudited) 1. Basis of Presentation Novanta Inc. (collectively with its subsidiaries, referred to as “Novanta”, the “Company”, “we”, “us”, “our”) is a leadingglobal supplier of core technology solutions that give medical and advanced industrial original equipment manufacturers (“OEMs”)a competitive advantage. The Company combines deep proprietary technology expertise and competencies in precision medicine,precision manufacturing, robotics and automation, and advanced surgery with a proven ability to solve complex technicalchallenges. This enables Novanta to engineer core components and sub-systems that deliver extreme precision and performance,tailored to the customers' demanding applications. The accompanying unaudited interim consolidated financial statements have been prepared by the Company in United States(“U.S.”) dollars and pursuant to the rules an